在卵巢癌的新辅助化疗期间的静脉血栓栓塞
Samuel Oxley1,2, Sarah Ahmed3, Kathryn Baxter4
1Wolfson Institute of Population Health, Queen Mary University of London, London, UK s.oxley@qmul.ac.uk.
概括
在接受新辅助化疗的晚期卵巢癌患者中,静脉血栓栓塞 (VTE) 的发病率很高. 这种情况显著影响治疗和生存,突出了预防措施的必要性.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 临床医学 临床医学
背景情况:
- 先进的上皮卵巢癌 (FIGO III/IV阶段) 带来了重大的治疗挑战.
- 新辅助化疗是晚期卵巢癌的标准治疗方法.
- 静脉血栓栓塞 (VTE) 是癌症患者的已知并发症,特别是那些正在接受治疗的人.
研究的目的:
- 为了确定接受新辅助化疗的晚期上皮卵巢癌患者的VTE发病率.
- 评估VTE对癌症治疗和患者死亡率的影响.
- 评估该患者队列中静脉瘤事件的时间和类型.
主要方法:
- 英国妇科癌症中心的多中心追溯审计.
- 包括接受新辅助化疗 (2021-2022) 的FIGOIII/IV期上皮卵巢癌患者.
- 排除在先前接受抗凝药或在开始化疗之前患有VTE的患者.
主要成果:
- 19.8%的患者从癌症呈现到出院时发生了静脉瘤.
- 10.9%的患者在开始新辅助化疗和术后出院之间发生了静脉瘤.
- 在5%的受影响患者中,VTE导致死亡,在28%的受影响患者中,治疗延迟/改变/取消导致死亡.
结论:
- 在接受新辅助化疗的晚期卵巢癌患者中,很大一部分患有VTE.
- 在这个队列中,VTE具有严重的临床后果,包括治疗中断和死亡率.
- 在这种高风险群体中,高的VTE发病率值得考虑进行血栓预防.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
238
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
238
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654


